Cargando…

Correlation Between Baseline Serum Tumor Markers and Clinical Characteristic Factors in Patients with Advanced Pancreatic Cancer

PURPOSE: In pancreatic cancer (PC), CA 19–9, CEA and CA 125 are the most widely used tumor markers. The aim of this study was to explore the prognostic significance of baseline levels of serum CA 19–9, CEA, and CA 125, and to evaluate the clinical significance of these markers in PC patients. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Guo-chao, Yan, Huan, Guo, Zhi-peng, Dai, Guanghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646411/ https://www.ncbi.nlm.nih.gov/pubmed/33173307 http://dx.doi.org/10.2147/OTT.S269720

Ejemplares similares

Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma
por: Chen, Yang, et al.
Publicado: (2017)

Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer
por: Chen, Shiyun, et al.
Publicado: (2023)

Survival of patients with advanced pancreatic cancer after iodine(125) seeds implantation brachytherapy: A meta-analysis
por: Han, Quanli, et al.
Publicado: (2017)

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma
por: Aarnink, Anne, et al.
Publicado: (2018)

The Value of Serum Tumor Markers and Blood Inflammation Markers in Differentiating Pancreatic Serous Cystic Neoplasms and Pancreatic Mucinous Cystic Neoplasms
por: Wang, Huan, et al.
Publicado: (2022)

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
por: Rückert, Felix, et al.
Publicado: (2010)

Nab-paclitaxel plus S-1 in advanced pancreatic adenocarcinoma (NPSPAC): a single arm, single center, phase II trial
por: Shi, Yan, et al.
Publicado: (2017)

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
por: Huang, Jian, et al.
Publicado: (2023)

S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study
por: Shi, Yan, et al.
Publicado: (2022)

Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
por: Yan, Wenji, et al.
Publicado: (2018)

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers
por: Brenner, B, et al.
Publicado: (2002)

A composite indicator of derived neutrophil–lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors
por: Chen, Shiyun, et al.
Publicado: (2022)

S100 as Serum Tumor Marker in Advanced Uveal Melanoma
por: Salzmann, Martin, et al.
Publicado: (2023)

Baseline Serum Estradiol Level Is Associated with Acute Kidney Injury in Patients with Moderately Severe and Severe Acute Pancreatitis
por: Pan, Jia-Jia, et al.
Publicado: (2022)

A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer
por: Cui, Hanzhi, et al.
Publicado: (2020)

A Composite Biomarker of Derived Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies
por: Pan, Yuting, et al.
Publicado: (2022)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection
por: Zhou, Qian, et al.
Publicado: (2023)

Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer
por: Suzuki, Hidetaka, et al.
Publicado: (2021)

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
por: Chen, Zhongqing, et al.
Publicado: (2019)

Development and Validation of Novel Nomograms Using Serum Tumor Markers for the Prediction of Preoperative Histologic Grades in Gastroenteropancreatic Neuroendocrine Tumors
por: Li, Yan, et al.
Publicado: (2021)

Effect of baseline serum vitamin D level on symptom and medication scores of subcutaneous immunotherapy in children with mite allergy
por: Jia, Xiaoxiao, et al.
Publicado: (2022)

Baseline correction of a correlation model for improving the prediction accuracy of infrared marker‐based dynamic tumor tracking
por: Akimoto, Mami, et al.
Publicado: (2015)

Identification of characteristic markers correlated with Th2 cell infiltration and metabolism molecular subtype in pancreatic adenocarcinoma
por: Xu, Zi-Jin, et al.
Publicado: (2022)

Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact
por: Mozas, Pablo, et al.
Publicado: (2020)

Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy
por: Yu, Shu-Lin, et al.
Publicado: (2017)

Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer
por: Fujiwara, Yutaka, et al.
Publicado: (2014)

Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors
por: Hijioka, Masayuki, et al.
Publicado: (2014)

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2019)

Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection
por: Guan, Shasha, et al.
Publicado: (2019)

Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer
por: Wu, Hsu, et al.
Publicado: (2019)

Potential Novel Serum Metabolic Markers Associated With Progression of Prediabetes to Overt Diabetes in a Chinese Population
por: Ren, Meng, et al.
Publicado: (2022)

Baseline Serum Bilirubin and Risk of First Stroke in Hypertensive Patients
por: Wang, Jiancheng, et al.
Publicado: (2020)

Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study
por: Mei, Zhou-Fang, et al.
Publicado: (2023)

Comprehensive analysis of serum tumor markers and BRCA1/2 germline mutations in Chinese ovarian cancer patients
por: Deng, Hongyu, et al.
Publicado: (2019)

Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer
por: Huang, Lei, et al.
Publicado: (2023)

Clinicopathological characteristics and prognosis of primary appendiceal stromal tumors
por: Zhang, Bao, et al.
Publicado: (2018)

The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years
por: Liu, Ting-ting, et al.
Publicado: (2017)

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
por: Li, Miaomiao, et al.
Publicado: (2020)

Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers
por: Hu, Xiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r5duvjncehvvbn6e4kbung17de